Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure adverse reactions to covid-19 vaccinations are appropriately (a) reported and (b) monitored.

The Medicines and Healthcare products Regulatory Agency (MHRA) continually monitors the safety of vaccines used in the United Kingdom vaccination programme. This is based on a range of sources, including spontaneous adverse drug reaction data from the UK’s Yellow Card scheme and other global regulators, with data on vaccine exposure from public health partners and information from epidemiological studies. The MHRA’s scientists review information on a daily basis for safety issues or unexpected rare events. This enables rapid detection of any new risks, weighed against the expected benefits. The weekly Yellow Card report summarises information on COVID-19 vaccines received via the scheme and includes the findings of safety investigations carried out by the MHRA.